INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 24 filers reported holding INTEC PHARMA LTD JERUSALEM in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $16,000 | -81.0% | 65,129 | -78.0% | 0.00% | – |
| Q2 2020 | $84,000 | +223.1% | 295,411 | +120.1% | 0.00% | – |
| Q1 2020 | $26,000 | -16.1% | 134,188 | +115.5% | 0.00% | – |
| Q4 2019 | $31,000 | -65.6% | 62,263 | -49.1% | 0.00% | – |
| Q3 2019 | $90,000 | -73.1% | 122,363 | +58.7% | 0.00% | – |
| Q2 2019 | $335,000 | – | 77,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |